Spotlighting Innovation in Novel Targeting Formats & Payloads to Enhance Delivery, Overcome Payload Resistance and Expand Therapeutic Reach
Non-cytotoxic payloads and differentiated targeting formats have become one of the most competitive and rapidly evolving areas in the precision oncology landscape.
The field has seen surging interest in antibody-degrader conjugates, antibody-oligonucleotide conjugates, multi-specific ADCs, fragment-drug conjugates and immune-stimulating payloads for overcoming drug resistance, improved therapeutic windows and to make an impact in cancers which don’t respond to traditional ADCs, as well as the exploration of non-oncology indications.
The 5th Novel Conjugates Summit is the industry’s only dedicated meeting for a comprehensive 3-day view into ‘what’s next beyond ADCs’, including which novel approaches are currently being explored, the scientific rationale behind each approach and how different targeting formats, linkers and payloads synergise to optimize the therapeutic index.
Whether your goal is to benchmark your pipeline, put your payload/format in the limelight, explore collaborations with complementary modalities, or stay ahead of fast-moving design trends, this summit offers a front-row seat to the next wave of conjugate innovation.
Participating in a small conference where you could get to know many of those working in the same or closely related fields was great. It was also great to see a wide range of conjugate formats discussed.
Prelude Therapeutics
The organizer has selected the topics and speakers very thoughtfully, which allowed broad enough but at the same time very focused and engaging conversations among attendees.
Salubris Biotherapeutics
There were many interesting topics, so I learned a lot. This summit brought together key people in this field, so it was also effective in expanding my network.
Daiichi Sankyo
Explore the Full Event Guide
- 20+ companies showcasing the rationale and data behind their approach in novel conjugate development
- 5+ pharma search & evaluation experts discussing partnerships within novel conjugates
- 6+ networking hours for learning from others in the space and forming brand new connections
- 2 deep dive workshops for cross-modality collaboration and optimising the design of novel conjugate drugs
- A poster session for allowing delegates to showcase cutting-edge work to the audience
Official Partners
Expertise Partners
Hosting Partners
Attending Companies Include
Explore the Agenda
Discover the latest differentiated approaches in bioconjugate design, from next-generation payloads to novel targeting formats. Gain deep insights through data-rich case studies, interactive workshops, and strategic panel discussions.
Partner With Us
Showcase your capabilities alongside leading CDMOs, technology providers, and biopharma innovators shaping the future of ADCs and next-generation conjugates. Position your brand at the center of industry-defining partnerships.
Join Conjugate Experts
Connect with the scientists, business developers, and external innovation leaders driving the evolution of targeted drug conjugates, and build the collaborations that will shape tomorrow’s precision therapeutics.